Apollo Endosurgery Inc Price/Sales
What is the Price/Sales of Apollo Endosurgery Inc?
The Price/Sales of Apollo Endosurgery Inc is 5.09
What is the definition of Price/Sales?
Price to sales ratio is a company’s stock price compared to its revenues.
ttm (trailing twelve months)
The price to sales ratio, Price/Sales ratio, P/S ratio, or PSR, is a valuation metric for stocks. It is calculated by dividing the company's market cap by the revenue in the most recent year. It can also be calculated by dividing the per-share stock price by per-share revenue. The price to sales ratio is for trailing twelve months so the reported sales are for the four previous quarters. Longer time periods can be examined at times.
A smaller price to sales ratio is usually thought to be a better investment since the investor is paying less for each unit of sales. However, sales do not reveal the whole picture, as the company may be unprofitable with a low P/S ratio. Because of the limitations, this ratio is usually used only for unprofitable companies, since they don't have a price to earnings ratio (P/E ratio). The metric can be used to determine the value of a stock relative to its past performance. It may also be used to determine relative valuation of a sector or the market as a whole.
Price to sales ratios vary greatly between sectors, so they are most useful in comparing similar stocks within a sector or sub-sector. Comparing P/S ratios carries the implicit assumption that all firms in the comparison have an identical capital structure.
Price/Sales of companies in the Health Care sector on NASDAQ compared to Apollo Endosurgery Inc
What does Apollo Endosurgery Inc do?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Companies with price/sales similar to Apollo Endosurgery Inc
- IFA Hotel & Touristik Aktiengesellschaft has Price/Sales of 5.09
- Red Violet Inc has Price/Sales of 5.09
- Allspring Global Dividend Opportunity Fund has Price/Sales of 5.09
- Garware Technical Fibres has Price/Sales of 5.09
- 49 North Resources has Price/Sales of 5.09
- Kings Infra Ventures has Price/Sales of 5.09
- Apollo Endosurgery Inc has Price/Sales of 5.09
- Norfolk Southern has Price/Sales of 5.09
- Boston Scientific has Price/Sales of 5.09
- Iradimed Corp has Price/Sales of 5.10
- Basellandschaftliche Kantonalbank has Price/Sales of 5.10
- China U-Ton has Price/Sales of 5.10
- Pool Safe has Price/Sales of 5.10